Share Name Share Symbol Market Type Share ISIN Share Description
Bioventix LSE:BVXP London Ordinary Share GB00B4QVDF07 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 2,450.00p 2,400.00p 2,500.00p 2,450.00p 2,450.00p 2,450.00p 10,316 06:37:40
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 5.5 4.2 69.2 35.4 124.92

Bioventix Share Discussion Threads

Showing 676 to 700 of 700 messages
Chat Pages: 28  27  26  25  24  23  22  21  20  19  18  17  Older
DateSubjectAuthorDiscuss
20/10/2017
16:30
Probably also worth noting that the "cautionary" tone of the results announcement probably cost Peter upwards of £0.25m on the shares he sold. I wonder what proportion of AIM CEOs would have done that?
gsbmba99
20/10/2017
14:57
I don't have a problem with the Director's sell. After creating so much value he quite naturally wants a new house or whatever. It's not like they cream big salaries and bonuses like most companies. And as for suggesting there's no more jam - the company has never promised more than thin gruel so I'm happy to assume there's caviar ahead (as usual!).
igbertsponk
20/10/2017
14:57
No, the party isn't over in my view. However, people are having a quick diet coke preparing themselves for the all night drinking fest to come...! :-))
ilovefrogs
20/10/2017
14:07
Re-posted because I missed out a key word Normally I would NOT take any notice of director dealings. When a huge chunk gets sold when normally only a few 1000 are bought/sold in any one day this makes me take notice, and strengthens my reasoning as to why I think this one has peaked.
soundsplausible
20/10/2017
14:03
Normally I would take any notice of director dealings. When a huge chunk gets sold when normally only a few 1000 are bought/sold in any one day this makes me take notice, and strengthens my reasoning as to why I think this one has peaked.
soundsplausible
20/10/2017
14:00
Is the party over for Bioventix, in that the continued rise has stopped and we are now in a general malaise? I ask as it peaked the other week at £29 and (for me) the statements in the final results regarding the future did not say that there was more jam coming any time soon.
soundsplausible
20/10/2017
11:20
Well that's one way to look at it I guess! the other way is to say that the man who best knows and understands the future of the Company has decided to reduce his exposure by £2m. You say potato, I say potarto...;-))
ilovefrogs
20/10/2017
10:45
Flipside is that there were buyers out there for £2m at the current price.
igbertsponk
20/10/2017
10:42
PH just sold £2m worth of stock. Understandable that he wants to monetize some of his holding, but unlikely to help the stock price short term methinks. As stated earlier, I'll buy some more if we get below £23 (not far off now!)
ilovefrogs
19/10/2017
12:50
Indeed ! I may add a few.
igbertsponk
19/10/2017
12:34
It's looking less exposed right now!
trident5
16/10/2017
17:26
Maynard Paton's latest investment blog: "Outstanding 2017 Results But Cagey Troponin Remarks May Leave 29x P/E Rather Exposed" hxxp://maynardpaton.com/2017/10/16/bioventix-outstanding-2017-results-but-cagey-troponin-remarks-may-leave-29x-pe-rather-exposed/
robinnicolson
16/10/2017
17:21
We'll have to agree to differ on the cash - I prefer the company to have the flexibility to get on and do what they want to without worrying about the bank balance. Means they can go and buy stuff (competitors, new agents) if they want to with ease. It's not like they're Amazon with umpteen trillion of excess wonga. I suspect we can agree on how much credence we give to Walbrock's thoughts....
igbertsponk
16/10/2017
16:39
Yep, and every year they generate a shag-load more of it and then pay out a special divvy as a result. They're very prudent which is absolutely fine by me, but given their business, and operational structure, they're rolling in it! I also agree that the Walbrock's English left much to be desired, but I think key man risk was what he was alluding to.
ilovefrogs
16/10/2017
16:24
Key Man Risk is somewhat different to "safety". I thought his post was just someone with little knowledge of the company having a go at analysing the results, with the aim of driving traffic to his website.
igbertsponk
16/10/2017
16:21
Well, the company disagrees with you "Our current view is that a cash balance of approximately GBP5 million is sufficient to facilitate operational and strategic agility with respect to possible corporate or technological opportunities that could arise in the foreseeable future. On this occasion, we have decided to distribute some surplus cash that is in excess of anticipated needs and accordingly, we are pleased to announce a special dividend of 40 pence per share."
igbertsponk
16/10/2017
16:11
re post 667 - actually, I think there IS masses of excess cash. I believe that the special divvy route is probably driven by what Harrision wants as it actually provides him a with a decent bit of income (to subsidise his rather low salary) without recourse to him selling shares.
ilovefrogs
16/10/2017
16:07
Igbert- I think he means there's key man risk, so and if one of them had an accident (eg fell under a bus) they'd be in a bit of trouble. I do think his post is ruined a bit by some dodgy numbers and internal inconsistencies. he talks about the PE being both 40.7x (wrong) and 29x (closer).
ilovefrogs
16/10/2017
14:38
Buybacks can be more tax efficient than divis for individuals. But they're generally driven by what institutional shareholders want. There isn't masses of excess cash - the company is distributing what it feels it can.
igbertsponk
16/10/2017
14:19
Why a buyback?
stepone68
16/10/2017
14:17
What on earth are you on about re staff accidents? They're not testing the stuff on themselves!
igbertsponk
16/10/2017
14:11
I would prefer a sharebuy back with excess cash
mngf
16/10/2017
14:02
Another good performance from Bioventix. Here is my analysis: Breakdown of results Results came in better than forecasted at £7.24m vs. £7.1m. Most of their sales come from royalty and license fee (£5.3m) with R&D and product revenue making up the rest. Pre-tax profit increased to £5.7m, compared to £4.2m giving the business a high margin in the 70s. The biggest surprise is the dividend announcement of a second interim dividend of 31p and a special dividend of 40p. Balance sheet A great balance sheet with cash making up 60% of total assets. No debt and no pension deficit. Cash Flow The balance sheet is neat with high levels of cash inflows and the only cash outflow is basically rewarding shareholders. Talking of dividends, this paid the company is paying 91p vs. 62.5p (including the special) Including the special, the yield climbs over 3%. But what impressed me the most is the 50% dividend growth helped by the special dividend increasing 100%. Is Bioventix fully-priced in? When you see revenue of £7.2m vs. the market cap. of £142m it looks pricey. And, despite EPS Growth averaging circa. 26% (which is typical of a sustainable rate for a small business) the market has raced ahead of itself. Market metrics such as: EV/EBIT = 27 times, now down to 24 times, the 6-year average is 13 times. PE = 40.7 times, now down to 29 times, the 6-year average is 19 times. PB = 17.3 times, now down to 14.1 times, the 6-year average is 7.3 times. PS = 25.8 times, now down to 19.7 times, the 6-year average is 10 times. On the flip-side: If you are a L-T investor, then you thinking five or ten years ahead. My advice is if Bioventix can sustain their business model, then we can make a hypothetical forecast. Assuming net profit grow by 20% for the next five years, then on current valuation, then PE comes to 11 times. And if the company keeps their current PE ratio of 29 times, you are looking at a share price of circa £70 per share! Things to be cautious Looking at Bioventix business and financials, I get the sense of feeling that their technology is reliance on a few talented staff (the company employs 15 people). So, staff safety and morale is paramount to Bioventix continuous success. Another is the entry of new competitors. Given the low cost of entry (all you need is the talent), then there is no guarantee of success if another business develops a superior product. Final Thoughts It reminds me of Rightmove with their high operating margin and low asset maintenance costs. Unlike Rightmove, they have vulnerabilities because the probability of staff accident can be fatal to future business success or a competitor muscling in (low cost of entry). So, in many ways they are competitive, but with a few speculative features lingering about. I think £20 per share or 21-times PE is good value. Interested in other companies’ updates and results, then click http://bit.ly/2ypK3dk
walbrock82
16/10/2017
10:34
Were the cost of sales really identical to last years' to the pound? 494,880? Assume so, as the columns add up properly.
igbertsponk
16/10/2017
10:27
They are also expecting China to come on line.
tadders2
Chat Pages: 28  27  26  25  24  23  22  21  20  19  18  17  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:32 V: D:20171020 23:28:20